Odd-Jorgen Maeland consults on matters involving valuation, general damages, investments, and structured finance products, such as mortgages and mortgage-backed securities. Mr. Maeland also has experience with healthcare and pharmaceutical matters, as well as executive compensation issues and securities class actions, such as In re Allergan PLC Securities Litigation and In Re: Kirkland Lake Gold Ltd. Securities Litigation. His work spans state and federal courts, including the Delaware Court of Chancery, and arbitration associations.
Valuation
Mr. Maeland consults on a variety of valuation disputes, with expertise in financial modeling, cash flow analysis, and relative valuation. His experience includes:
- Valuing private companies and pharmaceutical royalties in disputes relating to mergers and acquisitions (M&A)
- Conducting valuations of businesses involved in breach of contract disputes across a range of industries, including media and hospitality
- Valuing mineral rights for a complex international arbitration matter
General damages
Mr. Maeland analyzes damages arising from commercial disputes. His representative experience includes:
- Analyzing damages in real estate and structured finance matters
- Consulting on disputes alleging defamation in multiple industries and assessing related damages
- Evaluating economic and financial issues related to reimbursement disputes between healthcare providers and insurers
Investments and structured finance products
Mr. Maeland applies his skills in data analysis, valuation, and damages analysis to matters involving the management of investment fund capital. In real estate and structured finance matters, he has assessed the performance of residential mortgage-backed securities (RMBS) and investment funds. His work includes:
- Consulting on the execution of client orders by brokers and financial advisors
- Conducting damages analysis on behalf of an investment fund to calculate compensation for investors
- Assisting an investment fund with an internal investigation based on whistleblower allegations of trading misconduct
- Analyzing issues related to investments in real estate funds and portfolios
- Assessing investment funds’ documents and data in the context of regulatory investigations